203 related articles for article (PubMed ID: 27220230)
41. Avastin as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series.
Yeoh J; Williams C; Allen P; Buttery R; Chiu D; Clark B; Essex R; McCombe M; Qureshi S; Campbell WG
Clin Exp Ophthalmol; 2008 Jul; 36(5):449-54. PubMed ID: 18942219
[TBL] [Abstract][Full Text] [Related]
42. [Should associated intraoperative and/or postoperative photocoagulation be systematic during or after vitrectomy for proliferative diabetic vitreoretinopathy?].
Hajji Z; Rouillot JS; Roth P; Grange JD
J Fr Ophtalmol; 2003 Jan; 26(1):47-53. PubMed ID: 12610409
[TBL] [Abstract][Full Text] [Related]
43. RANDOMIZED CONTROLLED STUDY OF INTRAVITREAL BEVACIZUMAB 0.16 MG INJECTED ONE DAY BEFORE SURGERY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
Manabe A; Shimada H; Hattori T; Nakashizuka H; Yuzawa M
Retina; 2015 Sep; 35(9):1800-7. PubMed ID: 25932549
[TBL] [Abstract][Full Text] [Related]
44. Vitrectomy with fibrovascular membrane delamination for proliferative diabetic retinopathy with or without preoperative Avastin.
Papavasileiou E; Vasalaki M; Garnavou-Xirou C; Velissaris S; Zygoura V; McHugh D; Jackson TL
Hell J Nucl Med; 2017; 20 Suppl():161. PubMed ID: 29324931
[TBL] [Abstract][Full Text] [Related]
45. [Combined surgery, phacoemulsification, implantation of intraocular lens and pars plana vitrectomy].
Nawrocki J; Cisiecki S
Klin Oczna; 2004; 106(4-5):596-604. PubMed ID: 15646477
[TBL] [Abstract][Full Text] [Related]
46. Multiple factors in the prediction of risk of recurrent vitreous haemorrhage after sutureless vitrectomy for non-clearing vitreous haemorrhage in patients with diabetic retinopathy.
Ding Y; Yao B; Hang H; Ye H
BMC Ophthalmol; 2020 Jul; 20(1):292. PubMed ID: 32677996
[TBL] [Abstract][Full Text] [Related]
47. Comparative evaluation of vitrectomy and dye-enhanced ILM peel with grid laser in diffuse diabetic macular edema.
Kumar A; Sinha S; Azad R; Sharma YR; Vohra R
Graefes Arch Clin Exp Ophthalmol; 2007 Mar; 245(3):360-8. PubMed ID: 17093998
[TBL] [Abstract][Full Text] [Related]
48. Ultra-widefield fluorescein angiographic findings in patients with recurrent vitreous hemorrhage after diabetic vitrectomy.
Kim DY; Kim JG; Kim YJ; Joe SG; Lee JY
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7040-6. PubMed ID: 25298415
[TBL] [Abstract][Full Text] [Related]
49. Macular thickness changes after phacoemulsification in previously vitrectomized eyes for diabetic macular edema.
Horozoglu F; Yanyali A; Aytug B; Nohutcu AF; Keskinbora KH
Retina; 2011 Jun; 31(6):1095-100. PubMed ID: 21293315
[TBL] [Abstract][Full Text] [Related]
50. Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema.
Yanyali A; Nohutcu AF; Horozoglu F; Celik E
Am J Ophthalmol; 2005 May; 139(5):795-801. PubMed ID: 15860282
[TBL] [Abstract][Full Text] [Related]
51. Antivascular endothelial growth factor agents pretreatment before vitrectomy for complicated proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials.
Zhao XY; Xia S; Chen YX
Br J Ophthalmol; 2018 Aug; 102(8):1077-1085. PubMed ID: 29246890
[TBL] [Abstract][Full Text] [Related]
52. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
Chang W; Garg SJ; Maturi R; Hsu J; Sivalingam A; Gupta SA; Regillo CD; Ho AC
Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021
[TBL] [Abstract][Full Text] [Related]
53. Clinical manifestations of central retinal artery occlusion in eyes of proliferative diabetic retinopathy with previous vitrectomy and panretinal photocoagulation.
Chen SN; Chao CC; Hwang JF; Yang CM
Retina; 2014 Sep; 34(9):1861-6. PubMed ID: 24743637
[TBL] [Abstract][Full Text] [Related]
54. Four-port bimanual 23-gauge vitrectomy for diabetic tractional retinal detachment.
Wang ZY; Zhao KK; Li JK; Rossmiller B; Zhao PQ
Acta Ophthalmol; 2016 Jun; 94(4):365-72. PubMed ID: 26855122
[TBL] [Abstract][Full Text] [Related]
55. Vitrectomy for complications of proliferative diabetic retinopathy in young adults: clinical features and surgical outcomes.
Huang CH; Hsieh YT; Yang CM
Graefes Arch Clin Exp Ophthalmol; 2017 May; 255(5):863-871. PubMed ID: 28063082
[TBL] [Abstract][Full Text] [Related]
56. [Is removal of internal limiting membrane always necessary during surgery for refractory diffuse diabetic macular edema without evident epimacular proliferation?].
Aboutable T
Klin Monbl Augenheilkd; 2006 Aug; 223(8):681-6. PubMed ID: 16927225
[TBL] [Abstract][Full Text] [Related]
57. Factors influencing the results of vitreous surgery in diabetic retinopathy. I. Iris rubeosis and/or active neovascularization at the fundus.
Oldendoerp J; Spitznas M
Graefes Arch Clin Exp Ophthalmol; 1989; 227(1):1-8. PubMed ID: 2465937
[TBL] [Abstract][Full Text] [Related]
58. [Clinical observation of vitrectomy for treatment of diffuse nontraditional diabetic macular edema].
Liu DC; Wu H; Yang HQ
Zhonghua Yan Ke Za Zhi; 2011 Jun; 47(6):492-6. PubMed ID: 21914262
[TBL] [Abstract][Full Text] [Related]
59. Pars plana vitrectomy versus three intravitreal injections of bevacizumab for nontractional diabetic macular edema. A prospective, randomized comparative study.
Raizada S; Al Kandari J; Al Diab F; Al Sabah K; Kumar N; Mathew S
Indian J Ophthalmol; 2015 Jun; 63(6):504-10. PubMed ID: 26265641
[TBL] [Abstract][Full Text] [Related]
60. Planned foveal detachment technique for the resolution of diffuse diabetic macular edema.
Morizane Y; Kimura S; Hosokawa M; Shiode Y; Hirano M; Doi S; Hosogi M; Fujiwara A; Inoue Y; Shiraga F
Jpn J Ophthalmol; 2015 Sep; 59(5):279-87. PubMed ID: 26220819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
